Understanding how the body clears certain viruses from the blood
Clearance of Blood-Borne Arboviruses
['FUNDING_R01'] · UNIVERSITY OF COLORADO DENVER · NIH-11001238
This study is looking at how your immune system fights off viruses like chikungunya and Zika, focusing on the special cells and receptors that help clear these viruses from your body, with the hope of finding better treatments for these infections.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF COLORADO DENVER (nih funded) |
| Locations | 1 site (Aurora, UNITED STATES) |
| Trial ID | NIH-11001238 on ClinicalTrials.gov |
What this research studies
This research investigates how the immune system clears blood-borne arboviruses, such as chikungunya and Zika, from the body. It focuses on the role of specific immune cells and receptors in the clearance process, which is crucial for understanding viral transmission and disease severity. By studying the mechanisms involved in viral clearance, the research aims to identify potential targets for antiviral therapies. Patients may benefit from insights that could lead to improved treatments for arboviral infections.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals who have been infected with arboviruses or are at risk of such infections.
Not a fit: Patients with non-arboviral infections or those who are not at risk for arboviral diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that enhance the body's ability to clear arboviruses.
How similar studies have performed: Previous research has shown success in understanding immune responses to viral infections, making this approach promising but still exploring novel aspects of arboviral clearance.
Where this research is happening
Aurora, UNITED STATES
- UNIVERSITY OF COLORADO DENVER — Aurora, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MORRISON, THOMAS E — UNIVERSITY OF COLORADO DENVER
- Study coordinator: MORRISON, THOMAS E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.